Helmut Klein

Active 1982–2025

72
Papers
31,903
Citations
66
h-index
71
i10-index

Citations

Citations per year for Helmut Klein1972: 1 citations1981: 1 citations1984: 3 citations1986: 3 citations1989: 1 citations1991: 2 citations1992: 1 citations1993: 1 citations1994: 2 citations1995: 2 citations1996: 2 citations1997: 5 citations1998: 19 citations1999: 28 citations2000: 49 citations2001: 65 citations2002: 95 citations2003: 128 citations2004: 175 citations2005: 189 citations2006: 211 citations2007: 147 citations2008: 211 citations2009: 184 citations2010: 204 citations2011: 219 citations2012: 219 citations2013: 234 citations2014: 242 citations2015: 219 citations2016: 195 citations2017: 144 citations2018: 155 citations2019: 468 citations2020: 415 citations2021: 437 citations2022: 316 citations2023: 235 citations2024: 369 citations2025: 200 citations2026: 9 citations1973–1980: no citations, so these years are not shown1982–1983: no citations, so these years are not shown1985: no citations, so this year is not shown1987–1988: no citations, so these years are not shown1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,058 citing papers, 25.6% of this breakdownUnited Kingdom: 683 citing papers, 8.5% of this breakdownGermany: 596 citing papers, 7.4% of this breakdownNetherlands: 472 citing papers, 5.9% of this breakdownItaly: 467 citing papers, 5.8% of this breakdownCanada: 367 citing papers, 4.6% of this breakdownFrance: 342 citing papers, 4.3% of this breakdownChina: 251 citing papers, 3.1% of this breakdownSpain: 205 citing papers, 2.5% of this breakdownJapan: 183 citing papers, 2.3% of this breakdownAustralia: 182 citing papers, 2.3% of this breakdownSwitzerland: 181 citing papers, 2.3% of this breakdown
0%25.6%Other 25.4%

Fields

  • Medicine88.4%
  • Neuroscience5.4%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Engineering1.2%
  • Computer Science0.5%
  • Immunology and Microbiology0.3%
  • Other0.8%

Topics

  • Cardiac pacing and defibrillation studies15.2%
  • Cardiac electrophysiology and arrhythmias10.2%
  • Cardiac Arrhythmias and Treatments8.1%
  • Cardiovascular Function and Risk Factors5.8%
  • Atrial Fibrillation Management and Outcomes4.7%
  • Cardiac Imaging and Diagnostics4.5%
  • Other51.5%

Coauthors

All papers

Open in search
  1. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction

    Authors: , , , , , , , , , - New England Journal of Medicine 2002 cited by 6,873

  2. Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 3,139

  3. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy

    Authors: , , , , , , - The American Journal of Cardiology 2002 cited by 1,439

  4. Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1996 cited by 4,170

  5. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 cited by 374

  6. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure

    Authors: , , , , , , , , , , , , , - European Heart Journal 2010 cited by 520

  7. Reduction in Inappropriate Therapy and Mortality through ICD Programming

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 1,361

  8. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 838

  9. Upgrade of right ventricular pacing to cardiac resynchronization therapy in heart failure: a randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 cited by 77

  10. Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial

    Authors: , , , , , , , , , , , , , , , , , , - International Journal of Cardiology 2017 cited by 154

  11. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score

    Authors: , , , , , , , , , , , , , - European Heart Journal 2020 cited by 130

  12. Atrial Amyloidosis

    Authors: , , , , , , , - Circulation 2002 cited by 332

  13. Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial

    Authors: , , , , , , , , , - Circulation Arrhythmia and Electrophysiology 2011 cited by 186

  14. Impact of Autonomic Regulation Therapy in Patients with Heart Failure

    Authors: , , , , , , , , , , , - Circulation Heart Failure 2019 cited by 66

  15. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance

    Authors: , , , , , - American Heart Journal 2004 cited by 782

  16. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2000 cited by 584

  17. Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 352

  18. Cigarette smoking induces atrial fibrosis in humans via nicotine

    Authors: , , , , , , , - Heart 2007 cited by 164

  19. Comparison of Symptomatic and Functional Responses to Vagus Nerve Stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF

    Authors: , , , , , , , , , , , , - ESC Heart Failure 2020 cited by 75

  20. Characterization of Left Ventricular Activation in Patients With Heart Failure and Left Bundle-Branch Block

    Authors: , , , , , , , - Circulation 2004 cited by 588

  21. Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients

    Authors: , , , , , , , - Circulation 2015 cited by 239

  22. Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2008 cited by 804

  23. Predictors of Super-Response to Cardiac Resynchronization Therapy and Associated Improvement in Clinical Outcome

    Authors: , , , , , , , - Journal of the American College of Cardiology 2012 cited by 290

  24. Risk for Ventricular Fibrillation in Peripartum Cardiomyopathy with Severely Reduced Left Ventricular Function—Value of the Wearable Cardioverter/Defibrillator

    Authors: , , , , , , , , , , - European Journal of Heart Failure 2014 cited by 156